EXHIBIT 23.1
Published on June 23, 2017
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in these Prospectuses constituting a part of this Registration Statement of our reports dated February 24, 2017, relating to the financial statements and the effectiveness of Rexahn Pharmaceuticals, Inc.’s internal control over financial reporting appearing in the entity’s Annual Report on Form 10-K for the year ended December 31, 2016.
We also consent to the references to us under the captions “Experts” in these Prospectuses.
/s/ Baker Tilly Virchow Krause, LLP
Wyomissing, Pennsylvania
June 23, 2017